Drug elimination function of rat small intestine: Metabolism and intraluminal excretion

doi:10.1016/0006-2952(84)90068-6

Biochemical Pharmacology

Volume 33, Issue 20, 15 October 1984, Pages 3131-3136

https://doi.org/10.1016/0006-2952(84)90068-6 Get rights and content

Abstract

The metabolic and excretory function of the small intestine was investigated after oral and intravenous administration of drugs having an aromatic amino group to rats. After administration of drugs into the intestinal loop at the initial concentration of 0.1 mM, significant excretion of their N-acetylated forms into the lumen was observed. The amount of N-acetyl forms excreted in the lumen were 39.3 ± 3.5, 63.5 ± 20.9 and 18.0 ± 13.8% of disappeared drugs from the lumen for p-aminobenzoic acid (PABA), p-aminosalicylic acid and sulfanilic acid, respectively. The excretion of p-acetamidobenzoic acid (Ac-PABA) after the absorption of PABA was reduced by the coadministration with salicylic acid, benzoic acid and 2,4-dinitrophenol. Salicylic acid noncompetitively inhibited the acetylation of PABA by the intestinal N-acetyltransferase. A good correlation was found between the intestinal N-acetyltransferase activities for drugs and the intraluminal excretion of N-acetyl derivatives after intestinal absorption of drugs. These results indicate that a drug having a higher susceptibility to intestinal N-acetyltransferase would undergo a greater excretion into the lumen in its N-acetyl form after intestinal absorption. After intravenous administration of PABA at a dose of 100 μmole/kg, 4.02 ± 0.51% of dose was excreted in the lumen as Ac-PABA in 30min. On the other hand, a significantly smaller fraction (2.72 ± 0.68% of dose) was excreted in the lumen after intravenous injection of 100 μmole/kg of Ac-PABA. The larger excretion of Ac-PABA after administration of PABA indicates the contribution of intestinal metabolism on the transfer of PABA not only after oral, but also after intravenous administration.

References (25)

K. Turnheim et al.
Biochem. Pharmac.
(1977)
K. Turnheim et al.
Biochem. Pharmac.
(1977)
D.R. Holland et al.
J. pharmac. Sci.
(1976)
O.H. Lowry et al.
J. biol. Chem.
(1951)
R.T. Williams
Detoxication Mechanisms
T. Riggs et al.
J. biol. Chem.
(1951)
K.A. McMahon et al.
Fd Cosmet. Toxicol.
(1969)
K.F. Ilett et al.
W.H. Barr et al.
J. pharm. Sci.
(1970)
K.W. Bock et al.
Biochem. Pharmac.
(1975)

U. Breyer et al.

Biochem. Pharmac.

(1977)

K. Turnheim et al.

Naunyn-Schmiedeberg's Archs. Pharmac.

(1977)

Cited by (14)

Advanced imaging techniques for tracking drug dynamics at the subcellular level
2023, Advanced Drug Delivery Reviews
Optical microscopes are an important imaging tool that have effectively advanced the development of modern biomedicine. In recent years, super-resolution microscopy (SRM) has become one of the most popular techniques in the life sciences, especially in the field of living cell imaging. SRM has been used to solve many problems in basic biological research and has great potential in clinical application. In particular, the use of SRM to study drug delivery and kinetics at the subcellular level enables researchers to better study drugs’ mechanisms of action and to assess the efficacy of their targets in vivo. The purpose of this paper is to review the recent advances in SRM and to highlight some of its applications in assessing subcellular drug dynamics.
Influence of ionization and position of substituents on the solubility, solvation and transfer processes: A thermodynamic study of hydroxybenzamide and acetamidobenzoic acid isomers
2022, Journal of Molecular Liquids
Citation Excerpt :
Acetamidobenzoic acid (i-AcAmBA) and hydroxybenzamide (i-OHBZA) isomers (i = 2, 3, 4) were chosen as the objects of the investigation (Fig. 1). Acetamidobenzoic acid isomers are mainly known as the products of aminobenzoic acid metabolism [8–11]. Acetamidobenzoic acids are the related compounds of a number of acetaminophens, as well as phenacetin and acetanilide, which we studied earlier [6,7].
Solubility of i-hydroxybenzamides and i-acetamidobenzoic acids (i = 2, 3, 4) in buffer solutions (pH 2.0 and 7.4), 1-octanol and n-hexane were measured by the isothermal saturation method in the temperature range (293.15–315.15 K). The following order of the solubility was revealed (in mole fraction): 1-octanol > buffer pH 7.4 > buffer pH 2.0 > n-hexane. The solubility was correlated by the van’t Hoff and Apelblat equations. The best result was achieved with the van’t Hoff model. HYBOT descriptors for biologically active compounds have been calculated and the impact of the donor–acceptor capacity of the molecules on drug solubility has been studied. The thermodynamic parameters of solubility, solvation and transfer processes were calculated and discussed in view of solute–solvent interactions. A diagram approach was used to analyze the enthalpy and entropy contributions to the Gibbs energy of transfer processes from n-hexane to solvents and from buffer solutions to 1-octanol for the substances studied.
Polycyclic Aromatic Hydrocarbons: Part I. Exposure
2015, Advances in Clinical Chemistry
Citation Excerpt :
The lungs also excrete gasses such as carbon dioxide and volatile substances. The stomach and the intestine can also act as excretory organs for weak organic acids and bases [66,67]. Other less important routes of excretion include skin, hair, pancreas, saliva, and tears [68].
Polycyclic aromatic hydrocarbons (PAH) comprise the largest class of cancer-causing chemicals and are ranked ninth among chemical compounds threatening to humans. Although interest in PAH has been mainly due to their carcinogenic property, many of these compounds are genotoxic, mutagenic, teratogenic, and carcinogenic. They tend to bioaccumulate in the soft tissues of living organisms. Interestingly, many are not directly carcinogenic, but act like synergists. PAH carcinogenicity is related to their ability to bind DNA thereby causing a series of disruptive effects that can result in tumor initiation. Thus, any structural attribute or modification of a PAH molecule that enhances DNA cross linking can cause carcinogenicity. In part I, we review exposure to these dangerous chemicals across a spectrum of use in the community and industry.
Absorption and metabolic characteristics of p‐aminobenzoic acid and its Isomer, m‐aminobenzoic acid, from the rat small intestine
1991, Journal of Pharmaceutical Sciences
Absorption and metabolic characteristics of p-aminobenzoic acid (PABA) and m-aminobenzoic acid (MABA) from the rat small intestine were examined by means of in situ recirculation and in vitro everted sac experiments. p-Aminobenzoic acid was extremely rapidly absorbed from the rat small intestine, whereas the absorption of MABA, the m-isomer of PABA, was comparably slower. This finding was partly explained by the result that PABA is more lipophilic than MABA. The metabolite percentage of PABA was considerably greater than that of MABA in mucosal fluid, tissue, and serosal fluid. On the other hand, a concentration-dependent and a directional difference in the transfer rate of these drugs were observed in everted and noneverted sacs of rat small intestine. Furthermore, mucosal uptake of PABA or MABA was inhibited by 1 mM 2,4-dinitrophenol, 10 mM sodium azide, and pretreatment with HgCI₂ (10 mM). These results indicate that MABA, as well as PABA, is transported through the intestine by a carrier-mediated transport system, and that the molecular structure of these drugs is important for their absorption and metabolic characteristics.
Role of P-glycoprotein and the intestine in the excretion of DPC 333 [(2R)-2-{(3R)-3-amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl] -2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide] in rodents
2008, Drug Metabolism and Disposition
Presystemic metabolism of albendazole: Experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen
1999, Drug Metabolism and Disposition

View all citing articles on Scopus

^∗: To whom correspondence should be addressed at: Department of Pharmacy, Kyoto University Hospital, Sakyo-ku, Kyoto, 606, Japan.

^†: Present address: Faculty of Pharmaceutical Sciences, Okayama University, Tsushima naka 1-1-1, Okayama, 700, Japan.

View full text

Drug elimination function of rat small intestine: Metabolism and intraluminal excretion

Abstract

Biochem. Pharmac.

Biochem. Pharmac.

J. pharmac. Sci.

J. biol. Chem.

J. biol. Chem.

Fd Cosmet. Toxicol.

J. pharm. Sci.

Biochem. Pharmac.

Biochem. Pharmac.

Naunyn-Schmiedeberg's Archs. Pharmac.